FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23379 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Mental disorders NOS Mental disorder
mental retardering Intellectual disability
mental retardering, speciale Intellectual disability specialty
Mental handicap (specialty) Intellectual disability specialty
Mental handicap (specialty) Intellectual disability specialty
Mental handicap psychiatry department Intellectual disability psychiatry department (environment)
psykiatrisk afdeling for mental retardering Intellectual disability psychiatry service
årlig psykiatrisk undersøgelse udført Annual physical examination for people with mental illness completed
psykiatrisk kriseplan Mental health crisis plan
personlig psykiatrisk helbredsplan Mental health personal health plan
mental retardering Intellectual disability
Mental retardation NOS Intellectual disability
Mental retardation NOS Intellectual disability
Mental retardering, ikke nærmere specificeret Intellectual disability
Screening for mental retardering Intellectual disability screening
Screening for mentalt/udviklingsmæssigt handicap Screening for developmental disorder (procedure)
Screening for mentalt/udviklingsmæssigt handicap, ikke nærmere specificeret Screening for developmental disorder (procedure)
Mental/developmental handicap screening NOS Screening for developmental disorder (procedure)
menthol 35,55 mg inhalationspulver kapsel Product containing only menthol in pulmonary dose form (medicinal product form)
Mepacrine hydrochloride 100mg tablet Mepacrine hydrochloride 100 mg oral tablet
pethidinhydrochlorid 100 mg/ml injektionsvæske, opløsning, ampul Product containing only pethidine in parenteral dose form (medicinal product form)
pethidinhydrochlorid 50 mg/5 ml syrup Pethidine hydrochloride 10 mg/mL oral solution
pethidinhydrochlorid 50 mg/ml injektionsvæske, opløsning, ampul Product containing only pethidine in parenteral dose form (medicinal product form)
pethidinhydrochlorid 50 mg + promethazinhydrochlorid 50 mg injektionsvæske, opløsning, hætteglas Product containing only pethidine and promethazine (medicinal product)
mepivacainhydrochlorid 3 %/levonordefrin 1:20.000 injektionsvæske, opløsning, hætteglas Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection
mepivacainhydrochlorid 30 mg + natriumklorid 3 mg injektionsvæske, opløsning, hætteglas Mepivacaine only product
mepivacainhydrochlorid + adrenalin 2 %/1:100.000 cylinderampul Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection
Mepivacaine hydrochloride+epinephrine 2%/1:100,000 cartridge Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection
Meptazinol 100mg/1mL injection Product containing precisely meptazinol (as meptazinol hydrochloride) 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
meptazinol 100 mg/ml injektionsvæske, opløsning, ampul a 1 ml Product containing precisely meptazinol (as meptazinol hydrochloride) 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Meptazinol 200mg tablet Meptazinol (as meptazinol hydrochloride) 200 mg oral tablet
mercurophyllininjektion Mercurophylline
merselen-patch Polyester mesh (physical object)
Mesalamine 250mg capsule Product containing only mesalazine in oral dose form (medicinal product form)
mesalazin kapsel med modificeret udløsning a 250 mg Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 250mg prolonged-release oral capsule Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 375mg m/r capsule Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 375mg prolonged-release oral capsule Product containing only mesalazine in oral dose form (medicinal product form)
mesalazin 1 g/100 ml retentionsklysma Mesalazine only product in rectal dose form
Mesalazine 1g/100mL retention enema Mesalazine only product in rectal dose form
mesalazin 2 g/59 ml klysma Mesalazine only product in rectal dose form
Mesalazine 500mg/sachet gastro-resistant and prolonged-release oral granules Product containing only mesalazine in oral dose form (medicinal product form)
mesalazin 500 mg brev granulat med modificeret udløsning Product containing only mesalazine in oral dose form (medicinal product form)
Mesalazine duplicate deleted Product containing mesalazine (medicinal product)
Mesenteric venous thrombosis Thrombosis of mesenteric vein
Mesio-occlusion Mesio-occlusion of teeth
mesonefrisk tumor Wolffian tumor of uncertain behavior (morphologic abnormality)
mesoridazinbesylat 10 mg/ml injektionsvæske, opløsning, ampul Product containing precisely mesoridazine 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
mesoridazinbesylat 25 mg/ml injektionsvæske, opløsning, ampul Product containing precisely mesoridazine 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
Mesothelioma, biphasic, benign Mesothelioma, benign
metabolisk acidose forårsaget af indtagelse af medikamenter OG/ELLER kemiske stoffer Metabolic acidosis
Metabolic disease, NEC Metabolic disease
Metabolic function test NOS Metabolic function test
Metabolic function test NOS Metabolic function test
Metabolic marker Inborn errors of metabolism marker
Metabolic monitoring NOS Metabolic monitoring procedure
Metabolic monitoring NOS Metabolic monitoring procedure
Metacarpal X-ray Plain X-ray of metacarpal bone
Metacarpal X-ray Plain X-ray of metacarpal bone
Røntgenundersøgelse af metakarpalknogle Plain X-ray of metacarpal bone
Metaiodobenzylguanidine[123I] 74MBq/mL injection Iobenguane (131-I)-containing product in parenteral dose form
metaiodobenzylguanidin[123I] 74 MBq/ml pulver til injektionsvæske, opløsning, hætteglas Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I] 37MBq/mL injection Iobenguane (131-I)-containing product in parenteral dose form
metaiodobenzylguanidin[131I] 37 MBq/ml pulver til injektionsvæske, opløsning, hætteglas Iobenguane (131-I)-containing product in parenteral dose form
metaiodobenzylguanidin[131I] 370 MBq/ml injektionsvæske Iobenguane (131-I)-containing product in parenteral dose form
metaiodobenzylguanidin[131I] 37 MBq/ml diagnostisk injektionsvæske Iobenguane (131-I)-containing product in parenteral dose form
metaiodobenzylguanidin[131I] 9,25 MBq/ml diagnostisk injektionsvæske Iobenguane (131-I)-containing product in parenteral dose form
Metal engineering machiner NOS Engineering machiner
Metal engineering machiner NOS Engineering machiner
Metal processor/treater NOS Metal processer (occupation)
Metal processor/treater NOS Metal processer (occupation)
Metal production fitter NOS Metal production fitter
Metal production fitter NOS Metal production fitter
Metal/electrical worker NOS Metal/electrical worker
Metal/electrical worker NOS Metal/electrical worker
Metallocarboxypeptidase Metallocarboxypeptidase
Metalloproteinase Metalloproteinase
metaproterenol tablet a 20 mg Orciprenaline sulfate 20 mg oral tablet
metaproterenolsulfat 0,65 mg inhalationsaerosol Orciprenaline only product in pulmonary dose form
metaproterenolsulfat 15 mg/ml aerosol Product containing precisely orciprenaline sulfate 15 milligram/1 milliliter conventional release solution for inhalation (clinical drug)
metastasering stadium M1a American Joint Committee on Cancer cM1a (qualifier value)
metastasering stadium M1b American Joint Committee on Cancer cM1b (qualifier value)
metastasering stadium M1c American Joint Committee on Cancer cM1c (qualifier value)
metastasering stadium M2 American Joint Committee on Cancer cM1 (qualifier value)
metastasering stadium M3 American Joint Committee on Cancer cM1 (qualifier value)
metastasering stadium M4 American Joint Committee on Cancer cM1 (qualifier value)
metastasering stadium pM1 American Joint Committee on Cancer pM1 (qualifier value)
Metastasizing pleomorphic adenoma Pleomorphic adenoma
Metastatic apocrine adenocarcinoma to skin Metastatic apocrine adenocarcinoma (disorder)
Metastatic carcinoid tumor Metastatic well-differentiated neuroendocrine tumor (disorder)
Metastatic carcinoid tumor Metastatic well-differentiated neuroendocrine tumor (morphologic abnormality)
Metastatic carcinoma to female breast Metastatic carcinoma to breast
Metastatic carcinoma to male breast Metastatic carcinoma to breast
Metastatic cholangiocarcinoma to biliary tract Metastatic cholangiocarcinoma (morphologic abnormality)
Metastatic cholangiocarcinoma to perihilar bile duct Metastatic cholangiocarcinoma
Metastatic collecting duct carcinoma to kidney Metastatic collecting duct renal cell carcinoma (disorder)
Metastatic cystic renal cell carcinoma to kidney Metastatic cystic renal cell carcinoma
Metastatic eccrine porocarcinoma to skin Metastatic eccrine porocarcinoma
Metastatic infiltrating duct carcinoma to female breast Metastatic infiltrating duct carcinoma to breast (disorder)
Metastatic lobular carcinoma to breast Metastatic lobular carcinoma (disorder)
Metastatic lobular carcinoma to left female breast Metastatic lobular carcinoma (disorder)

Start Previous Page 114 of 234 Next End


Reference Sets

Reference set descriptor

Back to Start